Omega Healthcare Investors, Inc. $OHI Shares Purchased by Millennium Management LLC

Key Points

• Millennium Management LLC significantly increased its holdings in Omega Healthcare Investors by 293.9% during the first quarter, now owning over 1 million shares valued at approximately $40.9 million.
• Other institutional investors, including AQR Capital Management and Vanguard Group, also raised their stakes, indicating a total of 65.25% of the company's stock is held by hedge funds and institutional investors.
• In its latest earnings report, Omega Healthcare Investors beat analysts' expectations with an EPS of $0.77 and declared a quarterly dividend of $0.67 per share, resulting in an annualized yield of 6.3%.

Millennium Management LLC grew its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 293.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,075,223 shares of the real estate investment trust's stock after purchasing an additional 802,277 shares during the period. Millennium Management LLC owned about 0.37% of Omega Healthcare Investors worth $40,944,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of OHI. Vanguard Group Inc. increased its stake in shares of Omega Healthcare Investors by 3.9% during the first quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust's stock valued at $1,506,250,000 after buying an additional 1,492,904 shares during the period. Charles Schwab Investment Management Inc. increased its stake in shares of Omega Healthcare Investors by 2.9% during the first quarter. Charles Schwab Investment Management Inc. now owns 4,100,891 shares of the real estate investment trust's stock valued at $156,162,000 after buying an additional 114,665 shares during the period. Dimensional Fund Advisors LP increased its stake in shares of Omega Healthcare Investors by 4.3% during the first quarter. Dimensional Fund Advisors LP now owns 4,058,107 shares of the real estate investment trust's stock valued at $154,533,000 after buying an additional 165,554 shares during the period. Bank of New York Mellon Corp increased its stake in shares of Omega Healthcare Investors by 6.4% during the first quarter. Bank of New York Mellon Corp now owns 3,123,152 shares of the real estate investment trust's stock valued at $118,930,000 after buying an additional 188,481 shares during the period. Finally, AQR Capital Management LLC increased its stake in shares of Omega Healthcare Investors by 430.8% during the first quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust's stock valued at $108,989,000 after buying an additional 2,322,878 shares during the period. Hedge funds and other institutional investors own 65.25% of the company's stock.

Omega Healthcare Investors Stock Down 0.0%

Shares of OHI stock traded down $0.01 during trading hours on Friday, reaching $42.49. 1,550,013 shares of the company's stock were exchanged, compared to its average volume of 1,686,146. Omega Healthcare Investors, Inc. has a 1 year low of $35.04 and a 1 year high of $44.42. The stock has a market cap of $12.53 billion, a PE ratio of 26.23, a PEG ratio of 2.23 and a beta of 0.71. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The stock's fifty day moving average price is $40.26 and its two-hundred day moving average price is $38.23.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, topping analysts' consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The business had revenue of $235.60 million for the quarter, compared to analyst estimates of $248.49 million. During the same quarter in the previous year, the firm earned $0.71 earnings per share. The company's revenue was up 11.8% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Research analysts predict that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were paid a dividend of $0.67 per share. The ex-dividend date was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.3%. Omega Healthcare Investors's payout ratio is presently 165.43%.

Insider Buying and Selling at Omega Healthcare Investors

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the business's stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the sale, the director owned 18,654 shares in the company, valued at approximately $749,144.64. The trade was a 11.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.50% of the company's stock.

Analysts Set New Price Targets

OHI has been the topic of several research reports. Mizuho raised their price target on Omega Healthcare Investors from $37.00 to $40.00 and gave the company a "neutral" rating in a research note on Thursday. Wells Fargo & Company raised their price target on Omega Healthcare Investors from $41.00 to $44.00 and gave the company an "overweight" rating in a research note on Wednesday, August 27th. Truist Financial raised their price target on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a research note on Wednesday, September 3rd. Scotiabank lifted their target price on Omega Healthcare Investors from $39.00 to $42.00 and gave the company a "sector perform" rating in a research note on Thursday, August 28th. Finally, Raymond James Financial reiterated an "outperform" rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Five investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $43.75.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.